off
SOPHiA GENETICS Announces Instituto Mário Penna as New Customer
The hospital will enhance its testing and research of blood cancers with the SOPHiA DDM™ Platform BOSTON and ROLLE, Switzerland, May 20, 2024 /PRNewswire/ — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven...
Posted On 20 May 2024